Mats Dehlin

2.8k total citations · 1 hit paper
59 papers, 1.7k citations indexed

About

Mats Dehlin is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, Mats Dehlin has authored 59 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Nephrology, 30 papers in Rheumatology and 15 papers in Surgery. Recurrent topics in Mats Dehlin's work include Gout, Hyperuricemia, Uric Acid (35 papers), Spondyloarthritis Studies and Treatments (16 papers) and Urticaria and Related Conditions (11 papers). Mats Dehlin is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (35 papers), Spondyloarthritis Studies and Treatments (16 papers) and Urticaria and Related Conditions (11 papers). Mats Dehlin collaborates with scholars based in Sweden, United Kingdom and New Zealand. Mats Dehlin's co-authors include L. Jacobsson, Edward Roddy, Valgerður Sigurðardóttir, Maria Bokarewa, Anna Svärd, Eva Klingberg, Helena Forsblad‐d’Elia, Malin C. Erlandsson, Ulf Lindström and Johan Askling and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Journal of Leukocyte Biology.

In The Last Decade

Mats Dehlin

55 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors

2020 821 citations Mats Dehlin, L. Jacobsson et al. Nature Reviews Rheumatology profile →

Peers

Countries citing papers authored by Mats Dehlin

Since Specialization

Citations

This map shows the geographic impact of Mats Dehlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Dehlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Dehlin more than expected).

Fields of papers citing papers by Mats Dehlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Dehlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Dehlin. The network helps show where Mats Dehlin may publish in the future.

Co-authorship network of co-authors of Mats Dehlin

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Dehlin. A scholar is included among the top collaborators of Mats Dehlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Dehlin. Mats Dehlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health-related quality of life significantly improved in obese patients with psoriatic arthritis one year after a structured weight loss intervention 2025 ·Advances in Rheumatology ·(unknown), Annelie Bilberg, Björn Eliasson, (unknown), Mats Dehlin, L. Jacobsson, Ingrid Larsson, Eva Klingberg	2
2	Increased Incidence and Clinical Features of Septic Arthritis in Patients Aged 80 Years and above: A Comparative Analysis with Younger Cohorts 2024 ·Pathogens ·(unknown), Mats Dehlin, Tao Jin	3
3	Long-term ambient air pollution exposure and renal function and biomarkers of renal disease 2024 ·Environmental Health ·(unknown), Yiyi Xu, Eva M. Andersson, Anders Christensson, Mats Dehlin, Helena Forsblad‐d’Elia, Florencia Harari, Stefan Ljunggren, Péter Molnár, (unknown), Magnus Svartengren, Petter Ljungman, (unknown)	6
4	Sex and country differences in gout: cross-country comparison between Sweden and the UK 2023 ·Scandinavian Journal of Rheumatology ·Mats Dehlin, Sara Müller, Christian Mallen, (unknown), Lorraine Watson, L. Jacobsson, Edward Roddy	5
5	Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention 2023 ·Arthritis Research & Therapy ·(unknown), Charlotte Jonsson, Annelie Bilberg, Björn Eliasson, Luisa Torres, Mats Dehlin, L. Jacobsson, Inger Gjertsson, Ingrid Larsson, Eva Klingberg	9
6	Health-related quality of life by gout severity in women and men with gout in primary care: results from a questionnaire study in Western Sweden 2023 ·Scandinavian Journal of Rheumatology ·(unknown), L. Jacobsson, Eva Klingberg, (unknown), Mats Dehlin	1
7	Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden 2023 ·Scandinavian Journal of Rheumatology ·(unknown), Eva Klingberg, L. Jacobsson, (unknown), Mats Dehlin	6
8	Gout in Dalarna, Sweden – a population-based study of gout occurrence and compliance to treatment guidelines 2022 ·Scandinavian Journal of Rheumatology ·Valgerður Sigurðardóttir, Anna Svärd, L. Jacobsson, Mats Dehlin	8
9	Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study 2022 ·Frontiers in Medicine ·Mats Dehlin, Tatiana Zverkova Sandström, L. Jacobsson	16
10	Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis—a post-hoc analysis of pooled data from three phase 3 trials with secukinumab 2021 ·Rheumatology Advances in Practice ·Mats Dehlin, Andreas E. R. Fasth, Maximilian Reinhardt, L. Jacobsson	3
11	Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors breakdown → 2020 ·Nature Reviews Rheumatology ·Mats Dehlin, L. Jacobsson, Edward Roddy	821
12	The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project 2020 ·Arthritis Research & Therapy ·(unknown), Peter M. Nilsson, Carl Turesson, Mats Dehlin, Nicola Dalbeth, L. Jacobsson, Meliha C Kapetanovic	11
13	Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot 2020 ·Arthritis Research & Therapy ·(unknown), Helena Forsblad‐d’Elia, Oskar Angerås, Göran Bergström, Caroline Schmidt, L. Jacobsson, Mats Dehlin	12
14	Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy 2018 ·Arthritis Research & Therapy ·(unknown), Valgerður Sigurðardóttir, Anna Svärd, L. Jacobsson, Mats Dehlin	34
15	Pituitary dysfunction in granulomatosis with polyangiitis 2017 ·Pituitary ·Daniela Espósito, Penelope Trimpou, Dario Giugliano, Mats Dehlin, Óskar Ragnarsson	26
16	Factors associated with initiation and persistence of urate-lowering therapy 2017 ·Arthritis Research & Therapy ·Mats Dehlin, (unknown), Max Petzold, Ulf Strömberg, Gunilla Telg, L. Jacobsson	38
17	Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study 2017 ·Arthritis Research & Therapy ·Karin Lövgren Bengtsson, Helena Forsblad‐d’Elia, Elisabeth Lie, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, L. Jacobsson	109
18	Incidence and prevalence of gout in Western Sweden 2016 ·Arthritis Research & Therapy ·Mats Dehlin, (unknown), Valgerður Sigurðardóttir, Anna Svärd, L. Jacobsson	80
19	Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study 2016 ·BMC Musculoskeletal Disorders ·Karin Lövgren Bengtsson, L. Jacobsson, (unknown), (unknown), (unknown), Mats Dehlin, Elisabet Hilme, (unknown), Susanna M. Wallerstedt, Helena Forsblad‐d’Elia	13
20	Activation of Fms-Like Tyrosine Kinase 3 Signaling Enhances Survivin Expression in a Mouse Model of Rheumatoid Arthritis 2012 ·PLoS ONE ·S. Andersson, Mattias N. D. Svensson, Malin C. Erlandsson, Mats Dehlin, Karin Andersson, Maria Bokarewa	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact